AKT1 and non-small cell lung carcinoma: As shown in Fig. 4, AJ treatment markedly reduced the expression levels of p‐PI3K/PI3K, p‐Akt/Akt, and p‐NOS3/NOS3 in NSCLC cells compared with the control group, indicating the inhibitory effect of AJ on the PI3K-Akt signaling pathway.